Spyre Therapeutics Inc. (SYRE) — Net Asset Quality Index
Spyre Therapeutics Inc. (SYRE) has a Net Asset Quality Index of 87.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $763.95 Million minus total liabilities of $93.14 Million yields net assets of $670.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check SYRE asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Spyre Therapeutics Inc. Net Asset Quality Index Over Time (2013–2025)
This chart shows how Spyre Therapeutics Inc.'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 87.8%, representing net assets of $670.81 Million against total assets of $763.95 Million USD. See how liquid is Spyre Therapeutics Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Spyre Therapeutics Inc. (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Spyre Therapeutics Inc. from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Spyre Therapeutics Inc. market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $715.24 Million | $777.78 Million | $62.55 Million | ▲ +6.9 pp |
| 2024 | 85.1% | $517.80 Million | $608.48 Million | $90.68 Million | ▲ +31.3 pp |
| 2023 | 53.8% | $184.02 Million | $341.86 Million | $157.84 Million | ▼ -16.9 pp |
| 2022 | 70.7% | $50.30 Million | $71.14 Million | $20.84 Million | ▼ -5.7 pp |
| 2021 | 76.4% | $83.94 Million | $109.93 Million | $25.98 Million | ▼ -10.2 pp |
| 2020 | 86.5% | $139.83 Million | $161.62 Million | $21.79 Million | ▲ +14.3 pp |
| 2019 | 72.2% | $60.08 Million | $83.18 Million | $23.10 Million | ▼ -14.5 pp |
| 2018 | 86.7% | $67.43 Million | $77.74 Million | $10.31 Million | ▼ -3.0 pp |
| 2017 | 89.8% | $50.34 Million | $56.08 Million | $5.74 Million | ▼ -4.1 pp |
| 2016 | 93.9% | $62.97 Million | $67.06 Million | $4.10 Million | ▲ +0.5 pp |
| 2015 | 93.4% | $36.10 Million | $38.65 Million | $2.55 Million | ▲ +29.5 pp |
| 2014 | 63.9% | $1.87 Million | $2.93 Million | $1.06 Million | ▼ -5.4 pp |
| 2013 | 69.3% | $3.19 Million | $4.60 Million | $1.41 Million | — |